| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
82,270,000 |
| Market
Cap: |
222.13(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.67 - $31.13 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 8.1 |
| Insider 3/6 Months : 8.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
30,000 |
30,000 |
30,000 |
| Total Buy Value |
$0 |
$209,400 |
$209,400 |
$209,400 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
29,089 |
29,089 |
154,480 |
446,160 |
| Total Sell Value |
$143,717 |
$143,717 |
$3,162,442 |
$12,719,522 |
| Total People Sold |
4 |
4 |
5 |
5 |
| Total Sell Transactions |
4 |
4 |
11 |
27 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Foley Mark J |
Director |
– • – |
2017-09-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-08-23 |
4 |
AS |
$22.76 |
$519,031 |
D/D |
(22,800) |
156,050 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-08-23 |
4 |
OE |
$2.55 |
$844 |
D/D |
331 |
178,850 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-06-30 |
4 |
A |
$18.32 |
$11,064 |
D/D |
604 |
60,170 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-06-30 |
4 |
A |
$18.32 |
$18,318 |
D/D |
1,000 |
178,519 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-06-12 |
4 |
OE |
$2.55 |
$21,165 |
D/D |
8,300 |
177,519 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-05-30 |
4 |
OE |
$2.55 |
$12,750 |
D/D |
5,000 |
169,219 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-05-26 |
4 |
OE |
$8.70 |
$200,100 |
D/D |
23,000 |
59,566 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-05-24 |
4 |
AS |
$20.35 |
$401,091 |
D/D |
(19,713) |
164,219 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-05-22 |
4 |
S |
$20.20 |
$36,212 |
D/D |
(1,793) |
36,566 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-05-22 |
4 |
AS |
$20.20 |
$248,159 |
D/D |
(12,287) |
183,932 |
|
- |
|
| Vickers Philip J. |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Eastman Ronald W |
Director |
– • • |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Gangolli Julian S |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Byrnes Robert F |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Russell Angus C. |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Gardner Phyllis |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-03-16 |
4 |
D |
$19.20 |
$24,366 |
D/D |
(1,269) |
38,359 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-03-16 |
4 |
D |
$19.20 |
$60,885 |
D/D |
(3,171) |
196,219 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-02-22 |
4 |
AS |
$20.56 |
$227,050 |
D/D |
(11,037) |
199,390 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-01-28 |
4 |
D |
$20.00 |
$21,260 |
D/D |
(1,063) |
39,628 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,800 |
210,427 |
|
- |
|
| Joshi Abhay |
Chief Operating Officer |
• – – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,100 |
80,912 |
|
- |
|
| Silvernail Lauren P |
CFO, CBO & Secretary |
• – – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
40,691 |
|
- |
|
| Browne L Daniel |
CEO and President |
• • – |
2017-01-25 |
4 |
AS |
$19.78 |
$237,398 |
D/D |
(12,000) |
184,627 |
|
- |
|
397 Records found
|
|
Page 12 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.20 (6.9%) 
